bibliographicCitation |
Wu Z, Suppo J, Tumova S, Strope J, Bravo F, Moy M, Weinstein ES, Peer CJ, Figg WD, Chain WJ, Echavarren AM, Beech DJ, Beutler JA. Bridgehead Modifications of Englerin A Reduce TRPC4 Activity and Intravenous Toxicity but not Cell Growth Inhibition. ACS Med. Chem. Lett. 2020 Aug 03;11(9):1711–6. doi: 10.1021/acsmedchemlett.0c00186. |